Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 180.70
-12.40 (-6.42%)
Jul 21, 2026, 4:08 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 15.2 billion as of July 21, 2026.
Market Cap
15.20B
Enterprise Value
13.84B
Revenue
648.05M
Ranking
n/a
PE Ratio
68.13
Stock Price
180.70
ChartMarket Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 15.20B, an increase of 85.32%. That is a compound annual growth rate of 128.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 15.20B | 41.99% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 29.46B |
| The United Laboratories International Holdings | 18.07B |
| Grand Pharmaceutical Group | 18.07B |
| Sunshine Lake Pharma | 16.13B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Consun Pharmaceutical Group | 11.43B |
| CanSino Biologics | 9.63B |
| Shandong Xinhua Pharmaceutical Company | 9.12B |